China-based drug manufacturer Tianyin Pharmaceutical (TPI) is set to start test run at its 250-ton Jiangchuan Macrolide facility (JCM) for good manufacturing practice (GMP) certification process.
The company will conduct the test runs by the end of this month to investigate whether the plant is maintaining GMP.Additionally, the company will also verify its performance, efficiency, reliability and safety of the Azithromycin API manufacturing at JCM.Following the successful completion of the test runs the company will initiate the GMP certification process.
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back
Related stories
Latest stories
